Suppr超能文献

[在大鼠必需脂肪酸缺乏的情况下,海洋生物来源的ω-3 磷脂制剂对细胞内脂质代谢的调节作用]

[Regulation of intracellular lipid metabolism by the preparation of omega-3 phospholipids from marine organisms in deficiency of essential fatty acids in rats].

作者信息

Cherniavs'kyĭ P V, Datsenko Z M, Moiseieva L H, Kanivets' N V, Kozulina O P, Boroda A M, Abakumova O S

出版信息

Ukr Biokhim Zh (1999). 2006 Sep-Oct;78(5):101-13.

Abstract

It has been established that a deficit of essential fatty acids (EFA) in the animal organism induces specific modifications of composition of fatty acid (FA) of general phospholipids and plasmalogenic P1 in microsomal tissue membranes with various functions and affects the activity of phospholipase A2. It has been shown that arachidonic (AA), docosapentaenoic (DPA) and docosahexaenoic (DHA) acids in the composition of general phospholipids - phosphatidylcholine (PC), phosphatidylethanolamine (PEA) and plasmalogens PC and PEA react to EFA deficit in the organism. Quantitative redistribution of AA, DPA, DHA of FA in general phospholipids and plasmalogenic microsomal membranes depending on their functions was found under EFA deficit in the organism. Deficit of DHA and plasmalogenic phospholipids evidences that the status of cell plasmalogens affects the level of PUFA at EFA deficit in the organism. AA and DHA can be a selective target for plasmalogens. The drug of omega-3 phospholipids, considerable amount of DHA and eicosapentaenoic (EPA)FA being present in their structure, increases the amount of plasmalogens and decreases the amount of AA in the brain, heart and reproductive organs. It was also found that EFA deficit in the organism favours the increase of lisoPEA, lisoPC, free FA (FFA) connected with the increase of activity of endogenic phospholippase A2 and plasmalogen-selective phospholipase A2. The omega-3 phospholipase from marine organisms at EFA defecit decreases the amount of FFA, lisophospholipids and activity of phospholipase A2 in the microsomas of the studied tissues. The drug of omega-3 phospholipids normalizes the state and functions of the brain, liver, and heart tissues, reproductive organs against a background of EFA defecit and regulates the synthesis of biologocically active metabolites of AA in the organism.

摘要

已经确定,动物机体中必需脂肪酸(EFA)的缺乏会导致具有各种功能的微粒体组织膜中一般磷脂和缩醛磷脂P1的脂肪酸(FA)组成发生特定改变,并影响磷脂酶A2的活性。研究表明,一般磷脂(磷脂酰胆碱(PC)、磷脂酰乙醇胺(PEA))以及缩醛磷脂PC和PEA中的花生四烯酸(AA)、二十二碳五烯酸(DPA)和二十二碳六烯酸(DHA)会对机体中EFA的缺乏做出反应。在机体EFA缺乏的情况下,发现一般磷脂和微粒体缩醛磷脂膜中FA的AA、DPA、DHA会根据其功能进行定量重新分布。DHA和缩醛磷脂的缺乏表明,在机体EFA缺乏时,细胞缩醛磷脂的状态会影响多不饱和脂肪酸(PUFA)的水平。AA和DHA可能是缩醛磷脂的选择性靶点。ω-3磷脂药物,其结构中含有大量DHA和二十碳五烯酸(EPA)FA,可增加脑、心脏和生殖器官中缩醛磷脂的含量并减少AA的含量。还发现机体中EFA的缺乏有利于溶血PEA、溶血PC、游离脂肪酸(FFA)的增加,这与内源性磷脂酶A2和缩醛磷脂选择性磷脂酶A2活性的增加有关。在EFA缺乏时,来自海洋生物的ω-3磷脂酶会降低所研究组织微粒体中FFA、溶血磷脂的含量以及磷脂酶A2的活性。ω-3磷脂药物可在EFA缺乏的背景下使脑、肝脏、心脏组织和生殖器官的状态和功能恢复正常,并调节机体中AA生物活性代谢物的合成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验